(Q34405170)

2 August 2017

title

XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. (English)

1 reference

2 August 2017

0 references

1 reference

4

Gulbu Uzel

1 reference

2 August 2017

Feng-Yen Li

1

1 reference

2 August 2017

Benjamin Chaigne-Delalande

2

1 reference

2 August 2017

Helen Su

3

1 reference

2 August 2017

Helen Matthews

5

1 reference

2 August 2017

Michael J Lenardo

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

18 February 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

123

1 reference

2 August 2017

issue

14

1 reference

2 August 2017

page(s)

2148-2152

1 reference

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Second messenger role for Mg2+ revealed by human T-cell immunodeficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Epstein-Barr virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3975255

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24550228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacodynamics of Rituximab in Kidney Allotransplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24550228

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2013-11-538686

1 reference

2 August 2017

1 reference

2 August 2017

1 reference